Tox21_300599

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

89 API Suppliers, 31 USDMF, 32 CEP/COS, 12 JDMF, 26 EU WC, 51 KDMF, 27 NDC API, 46 Listed Suppliers

DEVELOPMENTS

64 Drug(s) in Development

64 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

24 Suppliers

24 Suppliers

DOSSIERs // Finished Dosage Formulations

331 Dossiers, 100 FDA Orange Book, 110 Europe, 34 Canada, 18 Australia, 19 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 200MG, CAPSULE;ORAL - 400MG, CAPSULE;ORAL - 50MG, TABLET;ORAL - EQ 10MG BASE;200MG, TABLET;ORAL - EQ 2.5MG BASE;200MG, TABLET;ORAL - EQ 5MG BASE;200MG

CAPSULE;ORAL - 100MG
CAPSULE;ORAL - 200MG
CAPSULE;ORAL - 400MG
CAPSULE;ORAL - 50MG
TABLET;ORAL - EQ 10MG BASE;200MG
TABLET;ORAL - EQ 2.5MG BASE;200MG
TABLET;ORAL - EQ 5MG BASE;200MG

RELATED EXCIPIENT COMPANIES

Suppliers, 20 BASF, 16 Kerry, 14 SPI Pharma, 11 Microlex e.U, 9 Gangwal Healthcare, 8 Boai NKY Pharmaceuticals Ltd, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Roquette, 6 Gangwal Chemicals, 5 Sigachi Industries, 4 ACG Worldwide, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Prachin Chemical, 3 DFE Pharma, 3 Ulanqab Kema New Material, 3 Lonza Capsugel, 3 Pharmatrans-Sanaq, 2 Ingredion Pharma Solutions, 2 Jai Radhe Sales, 2 Alcedo Pharmachem, 2 Vasa Pharmachem, 2 Nanjing Well Pharmaceutical, 1 DKSH, 1 Pfanstiehl, 1 NEWEDGE Overseas, 1 Minakem, 1 Finar, 1 Chynops Pharma, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Qualicaps, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Rochem International Inc, 1 Seppic

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 30 Direct Compression, 28 Disintegrants & Superdisintegrants, 19 Granulation, 18 Lubricants & Glidants, 14 Chewable & Orodispersible Aids, 12 Taste Masking, 12 Solubilizers, 10 Co-Processed Excipients, 8 Empty Capsules, 8 Thickeners and Stabilizers, 8 Coating Systems & Additives, 7 Parenteral, 5 Film Formers & Plasticizers, 5 Controlled & Modified Release, 3 API Stability Enhancers, 3 Topical, 2 Emulsifying Agents, 1 Rheology Modifiers

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 78 Finished Drug Prices

MARKET PLACE

14 APIs, 6 DOSSIERS // FDF

PATENTS

28 US Patents, 1 US Exclusivities, 6 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 3 EDQM Standards, 3 USP Standards, 21 Other Ref. Standards

DIGITAL CONTENT

5 Data Compilations & Company Tracker #PharmaFlow, 76 News

List of Suppliers

Full Screen View

Reset Filter

Price Info

Shandong Boyuan Pharmaceutical

Shandong Boyuan is a Chinese manufacturer of GMP & CEP APIs & pharmaceutical intermediates.

Contact Supplier

China

Virtual Booth

Digital Content

1-Methylcyclopropane-1-carboxylic acid

PDF Supplier PDF

URL Supplier Web Content

CAS Number

6914-76-7

End Use API

Celecoxib

About The Company

We are one of the well-known manufacturers of key APIs & intermediates in China, with 20 years of experie...

We are one of the well-known manufacturers of key APIs & intermediates in China, with 20 years of experience & presence in 20+ countries. At Boyuan, we are committed to providing high-quality products & services. Formerly known as “Jinan Boyuan Chemical Co., Ltd” & “Shandong Boyuan Chemical Co., Ltd.” Boyuan was founded in June 2001. We have 2 manufacturing plants in the cities of Jiyang & Yucheng in Shandong Province, China & both are in line with the GMP standard, following a strict quality system & conforming with international standards. Boyuan is dedicated to anti-cancer, anti-fungal & other APIs & intermediates associated.